Accendra Health, Inc. filed a Form 8-K on November 3, 2026, disclosing that Executive Vice President and Chief Operating Officer Perry A. Bernocchi entered into a transition agreement on October 29, 2026, under which he will cease to be an executive officer and serve as Strategic Advisor to the Chief Executive Officer through December 31, 2026.

Key Highlights

  • Transition agreement dated October 29, 2026: Perry A. Bernocchi, Executive Vice President and Chief Operating Officer, will step down from his executive officer role at Accendra Health, Inc.
  • New advisory role: According to the filing, Mr. Bernocchi will serve as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless his employment ends earlier.
  • Compensation preserved: The filing states Mr. Bernocchi will retain his current base salary and remain eligible for his 2026 annual bonus at his current target during the transition period.
  • Severance eligibility maintained: Mr. Bernocchi remains eligible for severance under the Company's Officer Severance Policy or his change of control severance agreement, as applicable, subject to the terms of those arrangements.
  • Exhibit filed: The transition agreement is filed as Exhibit 10.1 and incorporated by reference into the report.

Bernocchi COO Transition Details at Accendra Health

Accendra Health, Inc. (NYSE:ACH), a Virginia-incorporated company headquartered in Glen Allen, Virginia, disclosed through a current report that Perry A. Bernocchi, its Executive Vice President and Chief Operating Officer, signed a transition agreement with the company on October 29, 2026. Under this arrangement, Mr. Bernocchi will cease to hold the title of executive officer and will instead serve as Strategic Advisor to the Chief Executive Officer for a period ending no later than December 31, 2026, unless his employment concludes earlier.

According to the filing, during the transition period Mr. Bernocchi will continue to receive his current base salary and will remain eligible for his 2026 annual bonus at his current target level. The filing further states that he will retain eligibility for severance benefits either under the Company's Officer Severance Policy or under his change of control severance agreement, whichever is applicable, subject to the terms and conditions of those existing arrangements.

The filing notes that the description of the transition agreement "is qualified in its entirety by reference to the transition agreement," a copy of which was filed as Exhibit 10.1. The report was signed on November 3, 2026, by Jonathan A. Leon, Executive Vice President and Chief Financial Officer, on behalf of Accendra Health, Inc.

What Was Disclosed

Accendra Health, Inc. reported a leadership change under Item 5.02, disclosing that COO Perry A. Bernocchi entered a transition agreement on October 29, 2026, moving to a Strategic Advisor role through December 31, 2026, while retaining salary, bonus eligibility, and severance rights.